IQVIA Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Maximize Commercial Effectiveness
IQVIA™ (NYSE: IQV) today introduced OCE Optimizer, an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand. OCE Optimizer extends IQVIA's Orchestrated Customer Engagement solution by intelligently allocating commercial resources and interaction channels for more effective connections.
"The life sciences industry is becoming more dynamic and specialized," said Tal Rosenberg, senior vice president, Global Technology Solutions (News - Alert) at IQVIA. "The current environment is driving organizations to transform sales and marketing toward an increasingly digital model that orchestrates timely HCP touchpoints across multiple channels. OCE Optimizer provides customers with agile tools to adapt engagement strategies in response to market factors and prior HCP interactions."
Traditional long-range planning based on annual territory alignments is no longer sufficient. Life sciences companies are coordinating multiple customer-facing eams and interacting with a diverse set of decision-makers in healthcare networks. OCE Optimizer offers a new approach that creates and continuously updates rules-based workflows to create custom engagement plans across personal and digital channels.
OCE Optimizer leverages IQVIA's Ada machine learning algorithms to draw intelligent insights from varied information sources, including healthcare organization affiliations, call reports and access changes. With a detailed and current profile of every HCP, commercial teams then use OCE Optimizer to make on-demand course corrections to field alignments, segments and targets, and omnichannel engagement plans using visual tools and what-if scenarios for complex territory alignments.
For more information on OCE Optimizer, visit https://www.iqvia.com/oceoptimizer.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science - leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science - to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 67,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
How to Strategically Leverage New Connectivity Options